Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment

By sjmartinez • June 28, 2023

Gilham D, Wasiak S, Rakai BD, Fu L, Tsujikawa LM, Sarsons CD, Carestia A, Lebioda K, Johansson JO, Sweeney M, Kalantar-Zadeh K, Kulikowski E. Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment. Biomedicines. 2023 Jun 8;11(6):1663. doi: 10.3390/biomedicines11061663. PMID: 37371758.

Tags: apabetalone, BET proteins, chronic kidney disease (CKD), epigenetics, fibrosis, gene expression, Harbor UCLA, Inflammation, Nephrology, Publications

Lessons From the Past

Budoff MJ. Lessons From the Past. J Soc Cardiovasc Angiogr Interv. 2026 Mar 12;5(4):104276. doi: 10.1016/j.jscai.2026.104276. PMID: 42111096; PMCID: PMC13154623.

Five-Year Risk Prediction Models for Peripheral Artery Disease in Patients With Chronic Kidney Disease

Chen J, Tian L, Bundy JD, Jaeger BC, Zhang R, Li C, He H, Kumbala D, Chen CS, Garimella PS, Townsend RR, Rahman M, Jaar[...]

Reassessing alcohol consumption and cardiovascular disease by addressing bias in observational data: results from the Multi-Ethnic Study of Atherosclerosis

Srivatsa S, Farkouh EK, Stockwell T, Pike JR, Clay JM, Bey G, Nasir K, Budoff M, Naimi T, Farkouh ME. Reassessing alcohol consumption and cardiovascular[...]